Comparative Effectiveness of Fecal Immunochemical Test Outreach, Colonoscopy Outreach, and Usual Care for Boosting Colorectal Cancer Screening Among the Underserved A Randomized Clinical Trial

被引:207
|
作者
Gupta, Samir [1 ,2 ]
Halm, Ethan A. [3 ,4 ,5 ]
Rockey, Don C. [6 ]
Hammons, Marcia [7 ]
Koch, Mark [8 ]
Carter, Elizabeth [8 ]
Valdez, Luisa [7 ]
Tong, Liyue [3 ]
Ahn, Chul [3 ,4 ]
Kashner, Michael [9 ,10 ,11 ]
Argenbright, Keith [3 ,4 ,7 ]
Tiro, Jasmin [3 ,4 ]
Geng, Zhuo [12 ]
Pruitt, Sandi [3 ,4 ]
Skinner, Celette Sugg [3 ,4 ]
机构
[1] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA
[2] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA
[5] Univ Texas SW Med Ctr Dallas, Div Gen Internal Med, Dept Internal Med, Dallas, TX 75390 USA
[6] Med Univ S Carolina, Dept Internal Med, Charleston, SC USA
[7] Univ Texas Southwestern Med Ctr, Moncrief Canc Inst, Ft Worth, TX USA
[8] John Peter Smith Hlth Network, Dept Family Med, Ft Worth, TX USA
[9] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA
[10] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA
[11] Dept Vet Affairs, Off Acad Affiliat, Washington, DC USA
[12] Univ Texas Southwestern Med Sch, Dallas, TX USA
基金
美国国家卫生研究院;
关键词
OCCULT BLOOD-TESTS; LOW-INCOME; COLON; SIGMOIDOSCOPY; INTERVENTIONS; POPULATION; ADHERENCE; BARRIERS; DIVERSE; TRENDS;
D O I
10.1001/jamainternmed.2013.9294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Colorectal cancer (CRC) screening saves lives, but participation rates are low among underserved populations. Knowledge on effective approaches for screening the underserved, including best test type to offer, is limited. OBJECTIVE To determine (1) if organized mailed outreach boosts CRC screening compared with usual care and (2) if FIT is superior to colonoscopy outreach for CRC screening participation in an underserved population. DESIGN, SETTING, AND PARTICIPANTS We identified uninsured patients, not up to date with CRC screening, age 54 to 64 years, served by the John Peter Smith Health Network, Fort Worth and Tarrant County, Texas, a safety net health system. INTERVENTIONS Patients were assigned randomly to 1 of 3 groups. One group was assigned to fecal immunochemical test (FIT) outreach, consisting of mailed invitation to use and return an enclosed no-cost FIT (n = 1593). A second was assigned to colonoscopy outreach, consisting of mailed invitation to schedule a no-cost colonoscopy (n = 479). The third group was assigned to usual care, consisting of opportunistic primary care visit-based screening (n = 3898). In addition, FIT and colonoscopy outreach groups received telephone follow-up to promote test completion. MAIN OUTCOME MEASURES Screening participation in any CRC test within 1 year after randomization. RESULTS Mean patient age was 59 years; 64% of patients were women. The sample was 41% white, 24% black, 29% Hispanic, and 7% other race/ethnicity. Screening participation was significantly higher for both FIT (40.7%) and colonoscopy outreach (24.6%) than for usual care (12.1%) (P<.001 for both comparisons with usual care). Screening was significantly higher for FIT than for colonoscopy outreach (P <.001). In stratified analyses, screening was higher for FIT and colonoscopy outreach than for usual care, and higher for FIT than for colonoscopy outreach among whites, blacks, and Hispanics (P<.005 for all comparisons). Rates of CRC identification and advanced adenoma detection were 0.4% and 0.8% for FIT outreach, 0.4% and 1.3% for colonoscopy outreach, and 0.2% and 0.4% for usual care, respectively (P<.05 for colonoscopy vs usual care advanced adenoma comparison; P>.05 for all other comparisons). Eleven of 60 patients with abnormal FIT results did not complete colonoscopy. CONCLUSIONS AND REVELANCE Among underserved patients whose CRC screening was not up to date, mailed outreach invitations resulted in markedly higher CRC screening compared with usual care. Outreach was more effective with FIT than with colonoscopy invitation.
引用
收藏
页码:1725 / 1732
页数:8
相关论文
共 50 条
  • [21] Reduced and Full-Preparation CT Colonography, Fecal Immunochemical Test, and Colonoscopy for Population Screening of Colorectal Cancer: A Randomized Trial
    Sali, Lapo
    Mascalchi, Mario
    Falchini, Massimo
    Ventura, Leonardo
    Carozzi, Francesca
    Castiglione, Guido
    Delsanto, Silvia
    Mallardi, Beatrice
    Mantellini, Paola
    Milani, Stefano
    Zappa, Marco
    Grazzini, Grazia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
  • [22] Colorectal Cancer Screening by Colonoscopy, CT-Colonography, or Fecal Immunochemical Test
    Kuipers, Ernst J.
    Spaander, Manon C. W.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
  • [23] Fecal Immunochemical Test: A High Yield Colorectal Cancer Screening Tool in Underserved Population
    Singhal, Shashideep
    Arora, Ayush
    Scott, Larry
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S981 - S982
  • [24] Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored summit
    Gupta, Samir
    Coronado, Gloria D.
    Argenbright, Keith
    Brenner, Alison T.
    Castaneda, Sheila F.
    Dominitz, Jason A.
    Green, Beverly
    Issaka, Rachel B.
    Levin, Theodore R.
    Reuland, Daniel S.
    Richardson, Lisa C.
    Robertson, Douglas J.
    Singal, Amit G.
    Pignone, Michael
    CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (04) : 283 - 298
  • [25] Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score
    Sekiguchi, Masau
    Igarashi, Ataru
    Sakamoto, Taku
    Saito, Yutaka
    Esaki, Minoru
    Matsuda, Takahisa
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1555 - 1561
  • [26] Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics The STOP CRC Cluster Randomized Clinical Trial
    Coronado, Gloria D.
    Petrik, Amanda F.
    Vollmer, William M.
    Taplin, Stephen H.
    Keast, Erin M.
    Fields, Scott
    Green, Beverly B.
    JAMA INTERNAL MEDICINE, 2018, 178 (09) : 1174 - 1181
  • [27] EFFECTIVENESS OF PHONE PROMPT PRIOR TO MAILED FECAL IMMUNOCHEMICAL TEST (FIT) OUTREACH FOR PATIENTS WITH PREVIOUS NEGATIVE FIT: A RANDOMIZED CONTROLLED TRIAL
    Lee, Briton
    Patel, Shreya
    Rachocki, Carly
    Ladabaum, Uri
    Vittinghoff, Eric
    Somsouk, Ma
    GASTROENTEROLOGY, 2019, 156 (06) : S818 - S818
  • [28] Effectiveness and Cost of an Enhanced Mailed Fecal Test Outreach Colorectal Cancer Screening Program: Findings from the PROMPT Stepped-Wedge Trial
    Coronado, Gloria D.
    Nyongesa, Denis B.
    Escaron, Anne L.
    Petrik, Amanda F.
    Thompson, Jamie H.
    Smith, Dave
    Davis, Melinda M.
    Schneider, Jennifer L.
    Rivelli, Jennifer S.
    Laguna, Tanya
    Leo, Michael C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (11) : 1608 - 1616
  • [29] Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening A Randomized Clinical Trial
    Rat, Cedric
    Pogu, Corinne
    Le Donne, Delphine
    Latour, Chloe
    Bianco, Gaelle
    Nanin, France
    Cowppli-Bony, Anne
    Gaultier, Aurelie
    Nguyen, Jean-Michel
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (09): : 816 - 824
  • [30] OPT-IN VERSUS OPT-OUT COLORECTAL CANCER SCREENING OUTREACH: A RANDOMIZED CLINICAL TRIAL
    Mehta, Shivan J.
    Khan, Tanya
    Guerra, Carmen E.
    Reitz, Catherine
    McAuliffe, Timothy
    Volpp, Kevin
    Asch, David
    Doubeni, Chyke A.
    GASTROENTEROLOGY, 2018, 154 (06) : S768 - S769